Industry Research Reports

Home > Reports > Chemical & Material > Global Oxamide Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Oxamide Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Chemical & Material

Published Date: 2025-11-02

Pages: 133 Pages

Report ld: 5364520

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Oxamide Market Size(US$)

CAGR 2025-2031

4.3%

Market Size,2031

USD 135

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 105 million

Market Forecast in 2031(Value)

US$ 135 million

CAGR

4.3%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Oxamide market is projected to grow from US$ 102 million in 2024 to US$ 135 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Oxamide, with a molecular formula of (CONH₂)₂, is an organic compound that is a very stable colorless crystal or powder at room temperature. It is soluble in ethanol, slightly soluble in water, and insoluble in ether. It is a diamide derivative of oxalic acid, and cyanide is the anhydride of oxalyl diamide.

In recent years, with the continued growth in demand for high-performance plastics, electronic materials and environmentally friendly additives, the oxalamide market has gained stable development momentum. Especially in the fertilizer and chemical industries, oxalamide has gradually replaced some traditional additives with its excellent thermal stability and low toxicity, becoming an ideal choice for complying with environmental regulations. In addition, process improvements and optimization of synthetic routes have also continuously improved product purity and production efficiency, helping to expand the scope of application and reduce costs. However, the oxalamide market still faces some challenges, such as cost instability caused by fluctuations in upstream raw material prices and the high threshold of some synthetic technologies that limit the entry capabilities of small producers. In addition, there are other substitutes with similar performance on the market that may be competitive in terms of price or compliance. At the same time, as a specialty chemical, the production and application of oxalamide must comply with more stringent environmental protection and safety approval procedures, which also brings certain resistance to industrial expansion.

Report Includes:

This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Oxamide market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

AK Scientific
CRS Chemicals
Spectrum Chemical Mfg. Corp.
Thermo Fisher Scientific
KANTO
Merck
Otto Chemie Pvt. Ltd.

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

99%
98%
Others

Segment by Application

Fertilizers
Chemicals
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the Oxamide study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.

Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.

Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.

Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.

Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.

Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Introduction to Oxamide: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Oxamide Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 99%

1.2.3 98%

1.2.4 Others

1.3 Market Segmentation by Application

1.3.1 Global Oxamide Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Fertilizers

1.3.3 Chemicals

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Oxamide Revenue Estimates and Forecasts 2020-2031

2.2 Global Oxamide Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Oxamide Sales Estimates and Forecasts 2020-2031

2.4 Global Oxamide Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Global Production Analysis

3.1 Global Oxamide Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

4 Competition by Manufacturers

4.1 Global Oxamide Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global Oxamide Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 99% Market Size by Manufacturers

4.5.2 98% Market Size by Manufacturers

4.5.3 Others Market Size by Manufacturers

4.6 Global Oxamide Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

5 Global Product Segmentation Analysis

5.1 Global Oxamide Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global Oxamide Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

6 Global Downstream Application Analysis

6.1 Global Oxamide Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global Oxamide Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America Oxamide Sales and Revenue by Type (2020-2031)

7.4 North America Oxamide Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America Oxamide Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe Oxamide Sales and Revenue by Type (2020-2031)

8.4 Europe Oxamide Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe Oxamide Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific Oxamide Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific Oxamide Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific Oxamide Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America Oxamide Sales and Revenue by Type (2020-2031)

10.4 Central and South America Oxamide Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America Oxamide Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa Oxamide Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa Oxamide Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa Oxamide Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

12 Corporate Profile

12.1 AK Scientific

12.1.1 AK Scientific Corporation Information

12.1.2 AK Scientific Business Overview

12.1.3 AK Scientific Oxamide Product Models, Descriptions and Specifications

12.1.4 AK Scientific Oxamide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 AK Scientific Oxamide Sales by Product in 2024

12.1.6 AK Scientific Oxamide Sales by Application in 2024

12.1.7 AK Scientific Oxamide Sales by Geographic Area in 2024

12.1.8 AK Scientific Oxamide SWOT Analysis

12.1.9 AK Scientific Recent Developments

12.2 CRS Chemicals

12.2.1 CRS Chemicals Corporation Information

12.2.2 CRS Chemicals Business Overview

12.2.3 CRS Chemicals Oxamide Product Models, Descriptions and Specifications

12.2.4 CRS Chemicals Oxamide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 CRS Chemicals Oxamide Sales by Product in 2024

12.2.6 CRS Chemicals Oxamide Sales by Application in 2024

12.2.7 CRS Chemicals Oxamide Sales by Geographic Area in 2024

12.2.8 CRS Chemicals Oxamide SWOT Analysis

12.2.9 CRS Chemicals Recent Developments

12.3 Spectrum Chemical Mfg. Corp.

12.3.1 Spectrum Chemical Mfg. Corp. Corporation Information

12.3.2 Spectrum Chemical Mfg. Corp. Business Overview

12.3.3 Spectrum Chemical Mfg. Corp. Oxamide Product Models, Descriptions and Specifications

12.3.4 Spectrum Chemical Mfg. Corp. Oxamide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 Spectrum Chemical Mfg. Corp. Oxamide Sales by Product in 2024

12.3.6 Spectrum Chemical Mfg. Corp. Oxamide Sales by Application in 2024

12.3.7 Spectrum Chemical Mfg. Corp. Oxamide Sales by Geographic Area in 2024

12.3.8 Spectrum Chemical Mfg. Corp. Oxamide SWOT Analysis

12.3.9 Spectrum Chemical Mfg. Corp. Recent Developments

12.4 Thermo Fisher Scientific

12.4.1 Thermo Fisher Scientific Corporation Information

12.4.2 Thermo Fisher Scientific Business Overview

12.4.3 Thermo Fisher Scientific Oxamide Product Models, Descriptions and Specifications

12.4.4 Thermo Fisher Scientific Oxamide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 Thermo Fisher Scientific Oxamide Sales by Product in 2024

12.4.6 Thermo Fisher Scientific Oxamide Sales by Application in 2024

12.4.7 Thermo Fisher Scientific Oxamide Sales by Geographic Area in 2024

12.4.8 Thermo Fisher Scientific Oxamide SWOT Analysis

12.4.9 Thermo Fisher Scientific Recent Developments

12.5 KANTO

12.5.1 KANTO Corporation Information

12.5.2 KANTO Business Overview

12.5.3 KANTO Oxamide Product Models, Descriptions and Specifications

12.5.4 KANTO Oxamide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.5 KANTO Oxamide Sales by Product in 2024

12.5.6 KANTO Oxamide Sales by Application in 2024

12.5.7 KANTO Oxamide Sales by Geographic Area in 2024

12.5.8 KANTO Oxamide SWOT Analysis

12.5.9 KANTO Recent Developments

12.6 Merck

12.6.1 Merck Corporation Information

12.6.2 Merck Business Overview

12.6.3 Merck Oxamide Product Models, Descriptions and Specifications

12.6.4 Merck Oxamide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.6.5 Merck Recent Developments

12.7 Otto Chemie Pvt. Ltd.

12.7.1 Otto Chemie Pvt. Ltd. Corporation Information

12.7.2 Otto Chemie Pvt. Ltd. Business Overview

12.7.3 Otto Chemie Pvt. Ltd. Oxamide Product Models, Descriptions and Specifications

12.7.4 Otto Chemie Pvt. Ltd. Oxamide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.7.5 Otto Chemie Pvt. Ltd. Recent Developments

13 Value Chain and Supply-Chain Analysis

13.1 Oxamide Industry Chain

13.2 Oxamide Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 Oxamide Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 Oxamide Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

14 Oxamide Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

15 Key Findings in the Global Oxamide Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Oxamide Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Oxamide Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Oxamide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Oxamide Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Oxamide Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Oxamide Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)

Table 7. Global Oxamide Sales by Region (2020-2025) & (Tons)

Table 8. Global Oxamide Sales by Region (2026-2031) & (Tons)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Oxamide Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)

Table 11. Global Oxamide Production by Region (2020-2025) & (Tons)

Table 12. Global Oxamide Production by Region (2026-2031) & (Tons)

Table 13. Global Oxamide Sales by Manufacturers (2020-2025) & (Tons)

Table 14. Global Oxamide Sales Share by Manufacturers (2020-2025)

Table 15. Global Oxamide Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 16. Global Oxamide Revenue Market Share by Manufacturers (2020-2025)

Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 18. Global Oxamide by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxamide as of 2024)

Table 19. Global Oxamide Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 20. Global Oxamide Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)

Table 21. Key Manufacturers Oxamide Manufacturing Base and Headquarters

Table 22. Global Oxamide Market Concentration Ratio (CR5 and HHI)

Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 25. Global Oxamide Sales by Type (2020-2025) & (Tons)

Table 26. Global Oxamide Sales by Type (2026-2031) & (Tons)

Table 27. Global Oxamide Revenue by Type (2020-2025) & (US$ Million)

Table 28. Global Oxamide Revenue by Type (2026-2031) & (US$ Million)

Table 29. Global Oxamide ASP by Type (2020-2031) & (US$/Ton)

Table 30. Technical Specifications by Key Product Type

Table 31. Global Oxamide Sales by Application (2020-2025) & (Tons)

Table 32. Global Oxamide Sales by Application (2026-2031) & (Tons)

Table 33. Oxamide High-Growth Sectors Demand CAGR (2024-2031)

Table 34. Global Oxamide Revenue by Application (2020-2025) & (US$ Million)

Table 35. Global Oxamide Revenue by Application (2026-2031) & (US$ Million)

Table 36. Global Oxamide ASP by Application (2020-2031) & (US$/Ton)

Table 37. Top Customers by Region

Table 38. Top Customers by Application

Table 39. North America Oxamide Growth Accelerators and Market Barriers

Table 40. North America Oxamide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 41. North America Oxamide Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 42. Europe Oxamide Growth Accelerators and Market Barriers

Table 43. Europe Oxamide Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. Europe Oxamide Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 45. Asia-Pacific Oxamide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Asia-Pacific Oxamide Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 47. Asia-Pacific Oxamide Growth Accelerators and Market Barriers

Table 48. Southeast Asia Oxamide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 49. Central and South America Oxamide Investment Opportunities and Key Challenges

Table 50. Central and South America Oxamide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 51. Middle East and Africa Oxamide Investment Opportunities and Key Challenges

Table 52. Middle East and Africa Oxamide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 53. AK Scientific Corporation Information

Table 54. AK Scientific Description and Major Businesses

Table 55. AK Scientific Product Models, Descriptions and Specifications

Table 56. AK Scientific Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 57. AK Scientific Sales Value Proportion by Product in 2024

Table 58. AK Scientific Sales Value Proportion by Application in 2024

Table 59. AK Scientific Sales Value Proportion by Geographic Area in 2024

Table 60. AK Scientific Oxamide SWOT Analysis

Table 61. AK Scientific Recent Developments

Table 62. CRS Chemicals Corporation Information

Table 63. CRS Chemicals Description and Major Businesses

Table 64. CRS Chemicals Product Models, Descriptions and Specifications

Table 65. CRS Chemicals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 66. CRS Chemicals Sales Value Proportion by Product in 2024

Table 67. CRS Chemicals Sales Value Proportion by Application in 2024

Table 68. CRS Chemicals Sales Value Proportion by Geographic Area in 2024

Table 69. CRS Chemicals Oxamide SWOT Analysis

Table 70. CRS Chemicals Recent Developments

Table 71. Spectrum Chemical Mfg. Corp. Corporation Information

Table 72. Spectrum Chemical Mfg. Corp. Description and Major Businesses

Table 73. Spectrum Chemical Mfg. Corp. Product Models, Descriptions and Specifications

Table 74. Spectrum Chemical Mfg. Corp. Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 75. Spectrum Chemical Mfg. Corp. Sales Value Proportion by Product in 2024

Table 76. Spectrum Chemical Mfg. Corp. Sales Value Proportion by Application in 2024

Table 77. Spectrum Chemical Mfg. Corp. Sales Value Proportion by Geographic Area in 2024

Table 78. Spectrum Chemical Mfg. Corp. Oxamide SWOT Analysis

Table 79. Spectrum Chemical Mfg. Corp. Recent Developments

Table 80. Thermo Fisher Scientific Corporation Information

Table 81. Thermo Fisher Scientific Description and Major Businesses

Table 82. Thermo Fisher Scientific Product Models, Descriptions and Specifications

Table 83. Thermo Fisher Scientific Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 84. Thermo Fisher Scientific Sales Value Proportion by Product in 2024

Table 85. Thermo Fisher Scientific Sales Value Proportion by Application in 2024

Table 86. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2024

Table 87. Thermo Fisher Scientific Oxamide SWOT Analysis

Table 88. Thermo Fisher Scientific Recent Developments

Table 89. KANTO Corporation Information

Table 90. KANTO Description and Major Businesses

Table 91. KANTO Product Models, Descriptions and Specifications

Table 92. KANTO Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. KANTO Sales Value Proportion by Product in 2024

Table 94. KANTO Sales Value Proportion by Application in 2024

Table 95. KANTO Sales Value Proportion by Geographic Area in 2024

Table 96. KANTO Oxamide SWOT Analysis

Table 97. KANTO Recent Developments

Table 98. Merck Corporation Information

Table 99. Merck Description and Major Businesses

Table 100. Merck Product Models, Descriptions and Specifications

Table 101. Merck Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 102. Merck Recent Developments

Table 103. Otto Chemie Pvt. Ltd. Corporation Information

Table 104. Otto Chemie Pvt. Ltd. Description and Major Businesses

Table 105. Otto Chemie Pvt. Ltd. Product Models, Descriptions and Specifications

Table 106. Otto Chemie Pvt. Ltd. Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 107. Otto Chemie Pvt. Ltd. Recent Developments

Table 108. Key Raw Materials Distribution

Table 109. Raw Materials Key Suppliers

Table 110. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 111. Milestones in Production Technology Evolution

Table 112. Distributors List

Table 113. Market Trends and Market Evolution

Table 114. Market Drivers and Opportunities

Table 115. Market Challenges, Risks, and Restraints

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Oxamide Product Picture

Figure 2. Global Oxamide Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. 99% Product Picture

Figure 4. 98% Product Picture

Figure 5. Others Product Picture

Figure 6. Global Oxamide Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Fertilizers

Figure 8. Chemicals

Figure 9. Others

Figure 10. Oxamide Report Years Considered

Figure 11. Global Oxamide Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Oxamide Revenue (2020-2031) & (US$ Million)

Figure 13. Global Oxamide Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 14. Global Oxamide Revenue Market Share by Region (2020-2031)

Figure 15. Global Oxamide Sales (2020-2031) & (Tons)

Figure 16. Global Oxamide Sales (CAGR) by Region (2020-2031) (Tons)

Figure 17. Global Oxamide Sales Market Share by Region (2020-2031)

Figure 18. Global Oxamide Capacity, Production and Utilization (2020-2031) & (Tons)

Figure 19. Global Oxamide Production Trend by Region (2020-2031) (Tons)

Figure 20. Global Oxamide Production Market Share by Region (2020-2031)

Figure 21. Production Capacity Enablers & Constraints

Figure 22. Oxamide Production Growth Rate in North America (2020-2031) & (Tons)

Figure 23. Oxamide Production Growth Rate in Europe (2020-2031) & (Tons)

Figure 24. Oxamide Production Growth Rate in China (2020-2031) & (Tons)

Figure 25. Oxamide Production Growth Rate in Japan (2020-2031) & (Tons)

Figure 26. Top 5 and Top 10 Manufacturers Oxamide Sales Volume Market Share in 2024

Figure 27. Global Oxamide Revenue Market Share Ranking (2024)

Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 29. 99% Revenue Market Share by Manufacturer in 2024

Figure 30. 98% Revenue Market Share by Manufacturer in 2024

Figure 31. Others Revenue Market Share by Manufacturer in 2024

Figure 32. Type Eight Revenue Market Share by Manufacturer in 2024

Figure 33. Type Nine Revenue Market Share by Manufacturer in 2024

Figure 34. Global Oxamide Sales Market Share by Type (2020-2031)

Figure 35. Global Oxamide Revenue Market Share by Type (2020-2031)

Figure 36. Global Oxamide Sales Market Share by Application (2020-2031)

Figure 37. Global Oxamide Revenue Market Share by Application (2020-2031)

Figure 38. North America Oxamide Sales YoY (2020-2031) & (Tons)

Figure 39. North America Oxamide Revenue YoY (2020-2031) & (US$ Million)

Figure 40. North America Top 5 Manufacturers Oxamide Sales Revenue (US$ Million) in 2024

Figure 41. North America Oxamide Sales Volume (Tons) by Type (2020- 2031)

Figure 42. North America Oxamide Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 43. North America Oxamide Sales Volume (Tons) by Application (2020-2031)

Figure 44. North America Oxamide Sales Revenue (US$ Million) by Application (2020-2031)

Figure 45. US Oxamide Revenue (2020-2031) & (US$ Million)

Figure 46. Canada Oxamide Revenue (2020-2031) & (US$ Million)

Figure 47. Mexico Oxamide Revenue (2020-2031) & (US$ Million)

Figure 48. Europe Oxamide Sales YoY (2020-2031) & (Tons)

Figure 49. Europe Oxamide Revenue YoY (2020-2031) & (US$ Million)

Figure 50. Europe Top 5 Manufacturers Oxamide Sales Revenue (US$ Million) in 2024

Figure 51. Europe Oxamide Sales Volume (Tons) by Type (2020-2031)

Figure 52. Europe Oxamide Sales Revenue (US$ Million) by Type (2020-2031)

Figure 53. Europe Oxamide Sales Volume (Tons) by Application (2020-2031)

Figure 54. Europe Oxamide Sales Revenue (US$ Million) by Application (2020-2031)

Figure 55. Germany Oxamide Revenue (2020-2031) & (US$ Million)

Figure 56. France Oxamide Revenue (2020-2031) & (US$ Million)

Figure 57. U.K. Oxamide Revenue (2020-2031) & (US$ Million)

Figure 58. Italy Oxamide Revenue (2020-2031) & (US$ Million)

Figure 59. Russia Oxamide Revenue (2020-2031) & (US$ Million)

Figure 60. Asia-Pacific Oxamide Sales YoY (2020-2031) & (Tons)

Figure 61. Asia-Pacific Oxamide Revenue YoY (2020-2031) & (US$ Million)

Figure 62. Asia-Pacific Top 8 Manufacturers Oxamide Sales Revenue (US$ Million) in 2024

Figure 63. Asia-Pacific Oxamide Sales Volume (Tons) by Type (2020- 2031)

Figure 64. Asia-Pacific Oxamide Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 65. Asia-Pacific Oxamide Sales Volume (Tons) by Application (2020-2031)

Figure 66. Asia-Pacific Oxamide Sales Revenue (US$ Million) by Application (2020-2031)

Figure 67. Indonesia Oxamide Revenue (2020-2031) & (US$ Million)

Figure 68. Japan Oxamide Revenue (2020-2031) & (US$ Million)

Figure 69. South Korea Oxamide Revenue (2020-2031) & (US$ Million)

Figure 70. China Taiwan Oxamide Revenue (2020-2031) & (US$ Million)

Figure 71. India Oxamide Revenue (2020-2031) & (US$ Million)

Figure 72. Central and South America Oxamide Sales YoY (2020-2031) & (Tons)

Figure 73. Central and South America Oxamide Revenue YoY (2020-2031) & (US$ Million)

Figure 74. Central and South America Top 5 Manufacturers Oxamide Sales Revenue (US$ Million) in 2024

Figure 75. Central and South America Oxamide Sales Volume (Tons) by Type (2021-2031)

Figure 76. Central and South America Oxamide Sales Revenue (US$ Million) by Type (2020-2031)

Figure 77. Central and South America Oxamide Sales Volume (Tons) by Application (2020-2031)

Figure 78. Central and South America Oxamide Sales Revenue (US$ Million) by Application (2020-2031)

Figure 79. Brazil Oxamide Revenue (2020-2025) & (US$ Million)

Figure 80. Argentina Oxamide Revenue (2020-2025) & (US$ Million)

Figure 81. Middle East, and Africa Oxamide Sales YoY (2020-2031) & (Tons)

Figure 82. Middle East and Africa Oxamide Revenue YoY (2020-2031) & (US$ Million)

Figure 83. Middle East and Africa Top 5 Manufacturers Oxamide Sales Revenue (US$ Million) in 2024

Figure 84. Middle East and Africa Oxamide Sales Volume (Tons) by Type (2021-2031)

Figure 85. South America Oxamide Sales Revenue (US$ Million) by Type (2020-2031)

Figure 86. Middle East and Africa Oxamide Sales Volume (Tons) by Application (2020-2031)

Figure 87. Middle East and Africa Oxamide Sales Revenue (US$ Million) by Application (2020-2031)

Figure 88. GCC Countries Oxamide Revenue (2020-2025) & (US$ Million)

Figure 89. Turkey Oxamide Revenue (2020-2025) & (US$ Million)

Figure 90. Egypt Oxamide Revenue (2020-2025) & (US$ Million)

Figure 91. South Africa Oxamide Revenue (2020-2025) & (US$ Million)

Figure 92. Oxamide Industry Chain Mapping

Figure 93. Regional Oxamide Manufacturing Base Distribution (%)

Figure 94. Oxamide Production Process

Figure 95. Regional Oxamide Production Cost Structure

Figure 96. Channels of Distribution (Direct Vs Distribution)

Figure 97. Bottom-up and Top-down Approaches for This Report

Figure 98. Data Triangulation

Figure 99. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Oxamide market? zhanKai

The top companies in the global Oxamide market are AK Scientific、CRS Chemicals、Spectrum Chemical Mfg. Corp..

Which region is expected to have the highest market share? shouQi

What was the global market size of Oxamide in 2031? shouQi

What is the annual compound growth rate of the global Oxamide market size from 2025 to 2031? shouQi

What was the global market size of Oxamide in 2025? shouQi

Related Reports

Global Oxamide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Oxamide market size was US$ 105 million in 2025 and is forecast to reach a readjusted size of US$ 140 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 79
USD 4250.00
(Single User License)
Oxamide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Oxamide was estimated to be worth US$ 105 million in 2025 and is projected to reach US$ 140 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 99
USD 3950.00
(Single User License)
Global Oxamide Market Research Report 2026
The global Oxamide market was valued at US$ 105 million in 2025 and is anticipated to reach US$ 140 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 130
USD 2900.00
(Single User License)
Global Oxamide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Oxamide market size was US$ 102 million in 2024 and is forecast to a readjusted size of US$ 135 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 77
USD 4250.00
(Single User License)
Oxamide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oxamide was estimated to be worth US$ 102 million in 2024 and is forecast to a readjusted size of US$ 135 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-07-04
Pages: 102
USD 3950.00
(Single User License)
Global Oxamide Market Insights, Forecast to 2031
The global Oxamide market is projected to grow from US$ 105 million in 2025 to US$ 135 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period.
Published Date: 2025-07-04
Pages: 134
USD 4900.00
(Single User License)
Global Oxamide Market Research Report 2025
The global market for Oxamide was valued at US$ 102 million in the year 2024 and is projected to reach a revised size of US$ 135 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published Date: 2025-07-04
Pages: 91
USD 2900.00
(Single User License)
Oxamide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oxamide was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 88
USD 3950.00
(Single User License)
Global Oxamide Market Insights, Forecast to 2030
Oxamide is the organic compound with the formula (CONH2)2. This white crystalline solid is soluble in ethanol, slightly soluble in water and insoluble in diethyl ether. Oxamide is the diamide derived from oxalic acid, and the hydrate of cyanogen.
Published Date: 2024-04-12
Pages: 94
USD 4900.00
(Single User License)
Global Oxamide Market Research Report 2024
Oxamide is the organic compound with the formula (CONH2)2. This white crystalline solid is soluble in ethanol, slightly soluble in water and insoluble in diethyl ether. Oxamide is the diamide derived from oxalic acid, and the hydrate of cyanogen.
Published Date: 2024-01-17
Pages: 90
USD 2900.00
(Single User License)

Global Oxamide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Oxamide market size was US$ 105 million in 2025 and is forecast to reach a readjusted size of US$ 140 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 79
USD 4250.00 (Single User License)
Oxamide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Oxamide was estimated to be worth US$ 105 million in 2025 and is projected to reach US$ 140 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-03-06
Pages: 99
USD 3950.00 (Single User License)
Global Oxamide Market Research Report 2026
The global Oxamide market was valued at US$ 105 million in 2025 and is anticipated to reach US$ 140 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-03-06
Pages: 130
USD 2900.00 (Single User License)
Global Oxamide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Oxamide market size was US$ 102 million in 2024 and is forecast to a readjusted size of US$ 135 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 77
USD 4250.00 (Single User License)
Oxamide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oxamide was estimated to be worth US$ 102 million in 2024 and is forecast to a readjusted size of US$ 135 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-07-04
Pages: 102
USD 3950.00 (Single User License)
Global Oxamide Market Insights, Forecast to 2031
The global Oxamide market is projected to grow from US$ 105 million in 2025 to US$ 135 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period.
Published: 2025-07-04
Pages: 134
USD 4900.00 (Single User License)
Global Oxamide Market Research Report 2025
The global market for Oxamide was valued at US$ 102 million in the year 2024 and is projected to reach a revised size of US$ 135 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published: 2025-07-04
Pages: 91
USD 2900.00 (Single User License)
Oxamide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oxamide was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 88
USD 3950.00 (Single User License)
Global Oxamide Market Insights, Forecast to 2030
Oxamide is the organic compound with the formula (CONH2)2. This white crystalline solid is soluble in ethanol, slightly soluble in water and insoluble in diethyl ether. Oxamide is the diamide derived from oxalic acid, and the hydrate of cyanogen.
Published: 2024-04-12
Pages: 94
USD 4900.00 (Single User License)
Global Oxamide Market Research Report 2024
Oxamide is the organic compound with the formula (CONH2)2. This white crystalline solid is soluble in ethanol, slightly soluble in water and insoluble in diethyl ether. Oxamide is the diamide derived from oxalic acid, and the hydrate of cyanogen.
Published: 2024-01-17
Pages: 90
USD 2900.00 (Single User License)